OERTLE, S.; MAURON, H.; VILLIGER, P. Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders. Swiss Medical Weekly, [S. l.], v. 132, n. 2930, p. 414–414, 2002. DOI: 10.4414/smw.2002.10031. Disponível em: https://smw.ch/index.php/smw/article/view/197. Acesso em: 25 may. 2024.